The Paul, Weiss Litigation Department is led by a team of the country’s most accomplished trial lawyers. Our litigators handle the most complex and demanding lawsuits, class actions, government investigations, criminal prosecutions and restructurings. Our clients include Fortune 50 corporations and other prominent companies in the financial services, investment, medical device, pharmaceutical, sports, technology, energy, media and insurance industries. Every day, we are called on by chief executives, board chairs, general counsel, investors and entrepreneurs for our unmatched trial skills, sophisticated business judgment and renowned strategic advice.
Second Circuit Review: Court Declares Unconstitutional Law Banning Use of Prescriber Data
January 11, 2011
To read the article, click here.
Litigation partners Marty Flumenbaum and Brad Karp's Second Circuit Review column appeared in the December 29 issue of the New York Law Journal. The article discusses IMS Health Inc. v. Sorrell, in which the U.S. Court of Appeals for the Second Circuit struck down as unconstitutional a Vermont statute that banned the sale, transmission, or use of prescriber-identifiable data for marketing purposes by data mining companies and pharmaceutical manufacturers. Litigation associate Sharon Sorkin assisted in the preparation of the column.